Estimation of the Prevalence of Hepatic Dysfunction Among Dengue Infected Patients: A Hospital Based Cross-Sectional Study

Introduction: This study investigates the frequency of liver involvement in dengue patients and the potential of abnormal liver function tests as early indicators of illness severity. Results show a clear correlation between severe dengue outcomes and hepatic impairment, highlighting the importance of early detection and treatment for this public health concern. Aims: To assess the prevalence of liver dysfunction in Dengue patients and its association with Dengue-related complications. Materials and Methods: The present study was a Hospital based Observational Cross sectional study. This Study was conducted from February 2022 to June 2022 at Department of Biochemistry and Microbiology, Central Laboratory, OPD Biochemistry and Microbiology Laboratory, Medical College & Hospital, Kolkata. 121 dengue infected patients were included in our study. Result: The results indicate that the majority of participants were young to middle-aged, predominantly male, and mostly from urban areas. Fever was a universal symptom, with vomiting and abdominal pain also common. Liver enzyme levels were elevated in many patients, indicating varying degrees of hepatic dysfunction—most commonly mild to moderate. A significant association was found between the severity of dengue and liver dysfunction, with abnormal liver function more prevalent in severe cases. Moreover, patients with hepatic dysfunction had a higher incidence of ICU admission and mortality, highlighting liver involvement as a marker of worse clinical outcomes in dengue infection. Conclusion: In summary, the study findings highlight that hepatic dysfunction is prevalent among dengue patients, particularly in more severe forms of the disease. While most liver involvement is mild to moderate, its presence correlates with a higher likelihood of adverse outcomes. These results underscore the importance of early identification and monitoring of liver function in dengue patients, especially those presenting with warning signs or severe symptoms.

Authors

Publication Details

Journal
International Journal of Pharmaceutical Quality Assurance
Published
2025-01-01
DOI
https://doi.org/10.25258/ijpqa.16.5.08
Primary Topic
Mosquito-borne diseases and control
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Estimation of the Prevalence of Hepatic Dysfunction Among Dengue Infected Patients: A Hospital Based Cross-Sectional Study

Subhayan Lahiri, Arunangsu Chatterjee, Biyanka Sau, Amrita Chatterjee
International Journal of Pharmaceutical Quality Assurance
Mosquito-borne diseases and control
article

Estimation of the Prevalence of Hepatic Dysfunction Among Dengue Infected Patients: A Hospital Based Cross-Sectional Study

Subhayan Lahiri, Arunangsu Chatterjee, Biyanka Sau, Amrita Chatterjee
article en

Abstract

Introduction: This study investigates the frequency of liver involvement in dengue patients and the potential of abnormal liver function tests as early indicators of illness severity. Results show a clear correlation between severe dengue outcomes and hepatic impairment, highlighting the importance of early detection and treatment for this public health concern. Aims: To assess the prevalence of liver dysfunction in Dengue patients and its association with Dengue-related complications. Materials and Methods: The present study was a Hospital based Observational Cross sectional study. This Study was conducted from February 2022 to June 2022 at Department of Biochemistry and Microbiology, Central Laboratory, OPD Biochemistry and Microbiology Laboratory, Medical College & Hospital, Kolkata. 121 dengue infected patients were included in our study. Result: The results indicate that the majority of participants were young to middle-aged, predominantly male, and mostly from urban areas. Fever was a universal symptom, with vomiting and abdominal pain also common. Liver enzyme levels were elevated in many patients, indicating varying degrees of hepatic dysfunction—most commonly mild to moderate. A significant association was found between the severity of dengue and liver dysfunction, with abnormal liver function more prevalent in severe cases. Moreover, patients with hepatic dysfunction had a higher incidence of ICU admission and mortality, highlighting liver involvement as a marker of worse clinical outcomes in dengue infection. Conclusion: In summary, the study findings highlight that hepatic dysfunction is prevalent among dengue patients, particularly in more severe forms of the disease. While most liver involvement is mild to moderate, its presence correlates with a higher likelihood of adverse outcomes. These results underscore the importance of early identification and monitoring of liver function in dengue patients, especially those presenting with warning signs or severe symptoms.

International Journal of Pharmaceutical Quality Assurance
Openalex Percentile: Top 64%
Mosquito-borne diseases and control
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Estimation of the Prevalence of Hepatic Dysfunction Among Dengue Infected Patients: A Hospital Based Cross-Sectional Study — Subhayan Lahiri, Arunangsu Chatterjee, et al. · International Journal of Pharmaceutical Quality Assurance (2025) | TGRS Research Map | TGRS